Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Schedule of Disaggregation of Revenue

In the following table, revenue is disaggregated by primary geographical market, major product line, and timing of revenue recognition.

In thousands of US dollars ($)	Three Months Ended March 31,
Primary geographical markets	2022		2021
North America	$	318	$	208
Europe		46		84
Asia		116		268
	$	480	$	560

	Three Months Ended March 31,
Major products/services lines	2022		2021
Hardware	$	284	$	377
Consumables		40		102
Contract research services		15		6
Sample preparation accessories		31		29
Agrochem products		83		-
Technical support/extended service contracts		17		24
Shipping and handling		10		19
Other		-		3
	$	480	$	560

	Three Months Ended March 31,
Timing of revenue recognition	2022		2021
Products transferred at a point in time	$	448	$	538
Services transferred over time		32		22
	$	480	$	560

Schedule of Contract Balances

Contract balances

In thousands of US dollars ($)	March 31, 2022		December 31, 2021
Receivables, which are included in ‘Accounts Receivable’	$	292	$	155
Contract liabilities (deferred revenue)		48		41

Schedule of Future Related to Performance Obligations

In thousands of US dollars ($)	2022		2023		Total
Extended warranty service	$	46	$	3	$	49

Schedule of Customer Concentration Risk Percentage

The following table illustrates the level of concentration as a percentage of total revenues during the three months ended March 31, 2022 and 2021.

	For the Three Months Ended
	March 31,
	2022			2021
Top Five Customers		73	%		88	%
Federal Agencies		0	%		1	%

The following table illustrates the level of concentration as a percentage of net accounts receivable balance as of March 31, 2022 and December 31, 2021. The Top Five Customers category may include federal agency receivable balances if applicable.

	March 31, 2022			December 31, 2021
Top Five Customers		88	%		82	%
Federal Agencies		3	%		5	%

Schedule of Computation of Loss Per Share

The following table illustrates our computation of loss per share for the three months ended March 31, 2022 and 2021:

	For the Three Months Ended
	March 31,
	2022			2021
Numerator:
Net loss attributable to common stockholders	$	(4,671,834	)	$	(7,038,686	)
Denominator for basic and diluted loss per share:
Weighted average common stock shares outstanding		9,695,189			4,865,826
Loss per common share – basic and diluted	$	(0.48	)	$	(1.45	)

Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

	As of March 31,
	2022		2021
Stock options		1,307,822		1,358,490
Convertible debt		5,668,816		4,757,701
Common stock warrants		16,350,438		14,901,211
Convertible preferred stock:
Series D Convertible Preferred Stock		25,000		25,000
Series G Convertible Preferred Stock		26,857		26,857
Series H Convertible Preferred Stock		33,334		33,334
Series H2 Convertible Preferred Stock		70,000		70,000
Series J Convertible Preferred Stock		115,267		115,267
Series K Convertible Preferred Stock		229,334		229,334
Series AA Convertible Preferred Stock		8,649,000		8,083,000
		32,475,868		29,600,194

Schedule of Stock Based Compensation Expense

	For the Three Months Ended
	March 31,
	2022		2021
Cost of sales	$	4,349	$	5,053
Research and development		18,909		25,862
Selling and marketing		9,050		4,595
General and administrative		32,175		25,727
Total stock-based compensation expense	$	64,483	$	61,237

Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis

The following tables set forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2022:

			Fair value measurements at March 31, 2022 using:
	March 31, 2022		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Equity Securities	$	79,114	$	79,114		-		-
Total Financial Assets	$	79,114	$	79,114	$	-	$	-

The following tables set forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2021:

			Fair value measurements at December 31, 2021 using:
	December 31, 2021		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Equity Securities		59,976		59,976		-		-
Total Financial Assets	$	59,976	$	59,976	$	-	$	-